Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider Appointment and resignation of MD & CEO, Appointment and resignation of CFO and Appointment of Senior Management Personnel, Reconstitution of Committees, Closure of Wholly owned subsidiary and Grant of ESOP options